Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 100,200 shares, a decrease of 26.4% from the October 15th total of 136,100 shares. Based on an average daily volume of 472,700 shares, the days-to-cover ratio is currently 0.2 days. Currently, 16.0% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH initiated coverage on shares of Autonomix Medical in a research note on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 price objective for the company.

Autonomix Medical Stock Performance

NASDAQ:AMIX opened at $11.66 on Friday. Autonomix Medical has a 52 week low of $7.51 and a 52 week high of $152.00. The company has a fifty day simple moving average of $12.29 and a two-hundred day simple moving average of $22.85. The company has a quick ratio of 9.27, a current ratio of 4.26 and a debt-to-equity ratio of 0.36. The company has a market cap of $13.41 million and a price-to-earnings ratio of -0.70.

Autonomix Medical (NASDAQ:AMIX) last released its earnings results on Tuesday, August 13th. The company reported ($2.80) EPS for the quarter. As a group, equities analysts anticipate that Autonomix Medical will post -10 earnings per share for the current fiscal year.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.